125 related articles for article (PubMed ID: 31139414)
21. Somatic mutation in synchronous primary adenocarcinomas of the left lung: a case report.
Yu X; Sheng D; Jiang J; Ren M; Jin M; Xu S
Int J Clin Exp Pathol; 2015; 8(7):8579-84. PubMed ID: 26339437
[TBL] [Abstract][Full Text] [Related]
22. CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung.
Ozkan E; West A; Dedelow JA; Chu BF; Zhao W; Yildiz VO; Otterson GA; Shilo K; Ghosh S; King M; White RD; Erdal BS
AJR Am J Roentgenol; 2015 Nov; 205(5):1016-25. PubMed ID: 26496549
[TBL] [Abstract][Full Text] [Related]
23. Sequential small cell transformation and T790M mutation in an epidermal growth factor-mutant lung adenocarcinoma: A rare occurrence with significant management implications.
Shastri M; Gupta P; Gupta N; Singh N; Bal A; Srinivasan R; Khosla D
Cytopathology; 2022 Nov; 33(6):732-737. PubMed ID: 35867808
[TBL] [Abstract][Full Text] [Related]
24. A case of colorectal cancer with double-activating epidermal growth factor receptor mutations.
Rai K; Fujiwara K; Tsushima M; Kudo K; Mizuta M; Matsuo K; Yonei T; Yamadori I; Kiura K; Sato T
Jpn J Clin Oncol; 2011 Sep; 41(9):1138-41. PubMed ID: 21835826
[TBL] [Abstract][Full Text] [Related]
25. Adenocarcinoma of the Lung Acquiring Resistance to Afatinib by Transformation to Small Cell Carcinoma: A Case Report.
Nishimura J; Miyamoto Y; Fujimoto N; Ozeki T; Takada K; Asano M; Fuchimoto Y; Wada S; Ozaki S; Kishimoto T
Case Rep Oncol; 2017; 10(2):666-670. PubMed ID: 28878647
[TBL] [Abstract][Full Text] [Related]
26. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
Rafael OC; Lazzaro R; Hasanovic A
Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
[TBL] [Abstract][Full Text] [Related]
27. [The effective mutation of epidermal growth factor receptor in synchronous multiple primary lung cancers: study of clinical, radiographic and pathological factors].
Wang YJ; Feng H; Ma SR; Wang YC; Liu YY; Bai HJ; Zhao L
Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(29):2297-2301. PubMed ID: 31434406
[No Abstract] [Full Text] [Related]
28. Diagnosis of metachronous multiple lung adenocarcinoma at the cut-end by epidermal growth factor receptor mutation status discordance 4 years after sublobar resection for adenocarcinoma in situ: report of a case.
Isaka T; Yokose T; Ito H; Imamura N; Watanabe M; Imai K; Nishii T; Yamada K; Nakayama H; Masuda M
Surg Today; 2015 Oct; 45(10):1330-4. PubMed ID: 25377270
[TBL] [Abstract][Full Text] [Related]
29. Chromosomal imbalances in lung adenocarcinomas with or without mutations in the epidermal growth factor receptor gene.
Fong Y; Lin YS; Liou CP; Li CF; Tzeng CC
Respirology; 2010 May; 15(4):700-5. PubMed ID: 20409020
[TBL] [Abstract][Full Text] [Related]
30. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor mutation-specific immunohistochemical antibodies in lung adenocarcinoma.
Allo G; Bandarchi B; Yanagawa N; Wang A; Shih W; Xu J; Dalby M; Nitta H; To C; Liu N; Sykes J; Tsao MS
Histopathology; 2014 May; 64(6):826-39. PubMed ID: 24251405
[TBL] [Abstract][Full Text] [Related]
32. Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report.
Inagaki Y; Tamiya A; Matsuda Y; Azuma K; Adachi Y; Enomoto T; Kouno S; Taniguchi Y; Saijo N; Okishio K; Atagi S
Medicine (Baltimore); 2020 Oct; 99(42):e22628. PubMed ID: 33080698
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients.
Bacchi CE; Ciol H; Queiroga EM; Benine LC; Silva LH; Ojopi EB
Clinics (Sao Paulo); 2012; 67(5):419-24. PubMed ID: 22666783
[TBL] [Abstract][Full Text] [Related]
34. Concomitant T790M mutation and small-cell lung cancer transformation after acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor.
Fujita K; Kim YH; Yoshizawa A; Mio T; Mishima M
Respirol Case Rep; 2017 Jan; 5(1):e00206. PubMed ID: 28031840
[TBL] [Abstract][Full Text] [Related]
35. [Relationship between EGFR Mutations and Pathological Classification and
Specimen of Lung Adenocarcinoma].
Kang L; Zheng J; Zhu X
Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):382-388. PubMed ID: 28641695
[TBL] [Abstract][Full Text] [Related]
36. Can EGFR mutation status be reliably determined in pre-operative needle biopsies from adenocarcinomas of the lung?
Lindahl KH; Sørensen FB; Jonstrup SP; Olsen KE; Loeschke S
APMIS; 2015 Apr; 123(4):289-97. PubMed ID: 25556929
[TBL] [Abstract][Full Text] [Related]
37. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
Silva NN; Eng C
J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
[TBL] [Abstract][Full Text] [Related]
38. Small-cell lung cancer with a rare epidermal growth factor receptor gene mutation showing "wax-and-wane" transformation.
Takagi Y; Nakahara Y; Hosomi Y; Hishima T
BMC Cancer; 2013 Nov; 13():529. PubMed ID: 24195468
[TBL] [Abstract][Full Text] [Related]
39. Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
Lin Q; Cai GP; Yang KY; Yang L; Chen CS; Li YP
BMC Cancer; 2016 Aug; 16():593. PubMed ID: 27488410
[TBL] [Abstract][Full Text] [Related]
40. Molecular biological analysis in a patient with multiple lung adenocarcinomas.
Wakayama T; Hirata H; Suka S; Sato K; Tatewaki M; Souma R; Satoh H; Tamura M; Matsumura Y; Imada H; Sugiyama K; Arima M; Kurasawa K; Fukuda T; Fukushima Y
Thorac Cancer; 2018 May; 9(5):662-665. PubMed ID: 29577613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
